{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:48:52Z","timestamp":1791146932098,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s10549-006-9435-1","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T14:59:49Z","timestamp":1170428389000},"page":"87-94","source":"Crossref","is-referenced-by-count":96,"title":["Serial 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)"],"prefix":"10.1007","volume":"105","author":[{"given":"Jennifer M.","family":"Specht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda F.","family":"Kurland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"Gralow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah M.","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana K.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin K.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Dunnwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Mankoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,1]]},"reference":[{"key":"9435_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1991.9.3.509","volume":"9","author":"O Nielson","year":"1991","unstructured":"Nielson O, Munro A, Tannock I (1991) Bone metastases: pathophysiology and management policy. J Clin Oncol 9:509\u2013524","journal-title":"J Clin Oncol"},{"key":"9435_CR2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","volume":"80","author":"G Mundy","year":"1997","unstructured":"Mundy G (1997) Mechanisms of bone metastasis. Cancer 80:1546\u20131556","journal-title":"Cancer"},{"key":"9435_CR3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s003300050549","volume":"8","author":"D Vanel","year":"1998","unstructured":"Vanel D, Bittoun J, Tardivon A (1998) MRI of bone metastases. Eur J Radiol 8:1345\u20131351","journal-title":"Eur J Radiol"},{"key":"9435_CR4","first-page":"43","volume":"42","author":"R Bares","year":"1998","unstructured":"Bares R (1998) Skeletal scintigraphy in breast cancer management. J Nucl Med 42:43\u20138","journal-title":"J Nucl Med"},{"key":"9435_CR5","first-page":"152","volume":"46","author":"JM O\u2019Sullivan","year":"2002","unstructured":"O\u2019Sullivan JM, Cook GJ (2002) A review of the efficacy of bone scanning in prostate and breast cancer. J Nucl Med 46:152\u2013159","journal-title":"J Nucl Med"},{"key":"9435_CR6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejrad.2005.01.016","volume":"55","author":"N Ghanem","year":"2005","unstructured":"Ghanem N, Uhl M, Brink I et al. (2005) Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET\/CT for the detection of metastases of bone. Eur J Radiol 55:41\u201355","journal-title":"Eur J Radiol"},{"key":"9435_CR7","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2004.08.181","volume":"22","author":"T Hamaoka","year":"2004","unstructured":"Hamaoka T, Madewell JE, Podoloff DA et al. (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22:2942\u20132953","journal-title":"J Clin Oncol"},{"key":"9435_CR8","first-page":"1748","volume":"35","author":"J Schneider","year":"1994","unstructured":"Schneider J, Divgi C, Scott A (1994) Flare on bone scintography following taxol chemotherapy for metastatic breast cancer. J Nucl Med 35:1748\u20131752","journal-title":"J Nucl Med"},{"key":"9435_CR9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1200\/JCO.1995.13.5.1123","volume":"13","author":"CL Vogel","year":"1995","unstructured":"Vogel CL, Schoenfelder J, Shemano I et al. (1995) Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer. J Clin Oncol 13:1123\u20131128","journal-title":"J Clin Oncol"},{"issue":"Suppl1","key":"9435_CR10","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1007\/s00259-004-1537-6","volume":"31","author":"L Maffioli","year":"2004","unstructured":"Maffioli L, Florimonte L, Pagani L et al. (2004) Current role of bone scan with phosphonates in the follow-up of breast cancer. Eur J Nucl Med Mol Imag 31(Suppl1):S143\u2013S148","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"9435_CR11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.semnuclmed.2004.11.001","volume":"35","author":"W Eubank","year":"2005","unstructured":"Eubank W, Mankoff D (2005) Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med 35:84\u201399","journal-title":"Semin Nucl Med"},{"key":"9435_CR12","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","volume":"16","author":"GJ Cook","year":"1998","unstructured":"Cook GJ, Houston S, Rubens R et al. (1998) Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16:3375\u20133379","journal-title":"J Clin Oncol"},{"key":"9435_CR13","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00259-005-1842-8","volume":"32","author":"T Nakai","year":"2005","unstructured":"Nakai T, Okuyama C, Kubota T et al. (2005) Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imag 32:1253","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"9435_CR14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF02985050","volume":"19","author":"K Abe","year":"2005","unstructured":"Abe K, Sasaki M, Kuwabara Y et al. (2005) Comparison of 18FDG-PET with 99mTc-HMDP scintography for the detection of bone metastases in patients with breast cancer. Ann Nucl Med 19:573\u2013579","journal-title":"Ann Nucl Med"},{"key":"9435_CR15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1076-6332(03)80461-0","volume":"9","author":"SE Stafford","year":"2002","unstructured":"Stafford SE, Gralow JR, Schubert EK et al. (2002) Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy. Acad Radiol 9:913\u2013921","journal-title":"Acad Radiol"},{"key":"9435_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1200\/JCO.1998.16.1.173","volume":"16","author":"Y Sugawara","year":"1998","unstructured":"Sugawara Y, Fisher S, Zasakny K et al. (1998) Preclinical and clinical studies of bone marrow uptake of fluorine-18-fluorodexoyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol 16:173\u2013180","journal-title":"J Clin Oncol"},{"key":"9435_CR17","first-page":"235","volume":"27","author":"K Hamacher","year":"1986","unstructured":"Hamacher K, Coenen H, Stocklin G (1986) Efficient stereospecific synthesis of no-carrier added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235\u2013238","journal-title":"J Nucl Med"},{"key":"9435_CR19","first-page":"1044","volume":"44","author":"S Beaulieu","year":"2003","unstructured":"Beaulieu S, Kinahan P, Tseng J et al. (2003) SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences. J Nucl Med 44:1044\u20131050","journal-title":"J Nucl Med"},{"key":"9435_CR18","first-page":"135P","volume":"41","author":"B Lewellen","year":"2000","unstructured":"Lewellen B, Lewellen T, Mankoff D et al. (2000) A comparison between standard and segmented attenuation correction. J Nucl Med 41:135P","journal-title":"J Nucl Med"},{"key":"9435_CR20","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780195152968.001.0001","volume-title":"Applied longitudinal data analysis: modeling change and event occurence","author":"JD Singer","year":"2003","unstructured":"Singer JD, Willett JB (2003) Applied longitudinal data analysis: modeling change and event occurence. Oxford University Press, New York"},{"key":"9435_CR21","unstructured":"R: A language and environment for statistical computing. 2.0.1 R Foundation for Statistical Computing, Vienna, Austria"},{"key":"9435_CR22","first-page":"1356","volume":"46","author":"E Even-Sapir","year":"2005","unstructured":"Even-Sapir E (2005) Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med 46:1356\u20131367","journal-title":"J Nucl Med"},{"key":"9435_CR23","doi-asserted-by":"crossref","unstructured":"Peterson JJ, Kransdorf MJ, O\u2019Connor MI (2003) Diagnosis of occult bone metastases: positron emission tomography. Clin Orthop Relat Res S120-S128","DOI":"10.1097\/01.blo.0000093051.96273.7c"},{"key":"9435_CR24","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/1097-0142(20000615)88:12+<2927::AID-CNCR8>3.0.CO;2-V","volume":"88","author":"GJ Cook","year":"2000","unstructured":"Cook GJ, Fogelman I (2000) The role of positron emission tomography in the management of bone metastases. Cancer 88:2927\u20132933","journal-title":"Cancer"},{"key":"9435_CR25","first-page":"47","volume":"45","author":"GJ Cook","year":"2001","unstructured":"Cook GJ, Fogelman I (2001) Detection of bone metastases in cancer patients by 18F-fluoride and 18F-fluorodeoxyglucose positron emission tomography. Q J Nucl Med 45:47\u201352","journal-title":"Q J Nucl Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-006-9435-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-006-9435-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-006-9435-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:28:46Z","timestamp":1559219326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-006-9435-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["9435"],"URL":"https:\/\/doi.org\/10.1007\/s10549-006-9435-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,1]]}}}